A new study, conducted by the Atrial Fibrillation NETwork (AFNET), offered smartphone and arrhythmia screening to older adults without atrial fibrillation.
Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
‘Resistance breakers’ and better genetic tests are among new ways that scientists could address antimicrobial resistance, a new paper suggests.
Dr Jon Hazeldine, Research Fellow at the University of Birmingham, has been awarded a competitive MRC Career Development Award Fellowship totalling £1.2M.
The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis
UK analysis raises need for awareness of health implications for patients following abuse and neglect
The collaboration between University of Birmingham spin-off Marker Diagnostics, Rugby Football Union and World Rugby extended for the Women’s Rugby World Cup
Children and adult with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a CRCTU clinical trial.
Celebrating a bumper month for publishing across the College.
The International Eosinophil Society announce University of Birmingham researcher as a winner of the Gerald J. Gleich Award 2022.